{
  "meta": {
    "title": "Radionucleotide_Imaging",
    "url": "https://brainandscalpel.vercel.app/radionucleotide-imaging-d9e90335.html",
    "scrapedAt": "2025-11-30T11:20:38.529Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">NaF PET provides superior sensitivity and resolution compared to conventional bone scintigraphy for detecting skeletal metastases.</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallium-67 scan is routinely used in modern practice for detecting skeletal metastases.</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">18-FDG PET can detect both lytic and sclerotic bone metastases.</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">DOPA-PET is not typically used for evaluating skeletal metastases.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding imaging in skeletal metastases is incorrect?</span></p>",
      "unique_key": "DT1282649",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Gallium-67 </strong>is not routinely used for skeletal metastasis detection due to poor sensitivity and specificity in modern practice.</li>\n<li><strong>Gallium-67 scan</strong> has largely been replaced by more advanced and sensitive modalities.\n<ul>\n<li>It has limitations due to physiological uptake in normal tissues and low spatial resolution.</li>\n<li>Its role has shifted away from skeletal metastases evaluation and is now mostly historical.</li>\n</ul>\n</li>\n<li><strong>NaF PET (Sodium Fluoride PET)</strong>, on the other hand, offers excellent sensitivity and resolution for detecting osseous metastases, especially in prostate and breast cancer. <strong>(Option A ruled out)</strong>\n<ul>\n<li>It is best suited for the evaluation of bone metastasis.</li>\n</ul>\n</li>\n<li>18-FDG PET is widely used for evaluating metabolically active (often is lytic) metastases such as those from lung or breast cancer. <strong>(Option C ruled out)</strong></li>\n<li>DOPA-PET (used mainly for neuroendocrine tumours and certain brain pathologies) is not standard for skeletal metastasis assessment. <strong>(Option D ruled out)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721f58fc650-d3c6-4315-9e0f-fe7af60df8bd.png\">",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal nodular hyperplasia</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis of the liver</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male with a history of chronic alcohol use presents with hepatomegaly and vague abdominal discomfort. Liver function tests are mildly deranged. A Tc-99m sulfur colloid liver-spleen scan is performed. The scan shows reduced uptake in the liver and increased activity in the spleen and bone marrow. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1282658",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282658,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In <strong>cirrhosis</strong>, Tc-99m sulfur colloid scan typically shows <strong>reduced hepatic uptake</strong> with colloid shift to spleen and bone marrow due to Kupffer cell dysfunction.</p>\n<ul>\n<li><strong>Tc-99m sulfur colloid</strong> is taken up by functioning reticuloendothelial cells (Kupffer cells) in the liver, spleen, and bone marrow.</li>\n<li>In <strong>cirrhosis</strong>, hepatocyte and Kupffer cell function is impaired, reducing colloid uptake in the liver. As a result, there is a <strong>\"colloid shift\"</strong>, increased tracer localisation in the spleen and bone marrow. </li>\n</ul>\n<p><strong>Sulfur Colloid Scan:</strong></p>\n<ul>\n<li><strong>Tc-99m sulfur colloid</strong> is a radiopharmaceutical used for liver-spleen scintigraphy to evaluate reticuloendothelial (Kupffer cell) function and detect focal or diffuse hepatic abnormalities.</li>\n<li><strong>Mechanism:</strong> After IV injection, it localizes in tissues rich in phagocytic activity (Kupffer cells in the liver).</li>\n<li><strong>Normal Scan:</strong> Shows homogeneous tracer uptake in the liver with relatively less uptake in the spleen and bone marrow.</li>\n<li><strong>Uses:</strong>\n<ul>\n<li>Assess diffuse liver disease (e.g., cirrhosis).</li>\n<li>Differentiate focal liver lesions.</li>\n<li>Evaluate functional liver volume pre-surgery.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong> </p>\n<p><strong>Hepatocellular carcinoma (Option A)</strong> typically appears as a photogenic (cold) area but doesn't produce the diffuse colloid shift pattern seen in cirrhosis.</p>\n<p><strong>Focal nodular hyperplasia (Option B)</strong> contains Kupffer cells and would appear as a \"hotspot\" on the scan, not decreased hepatic uptake.</p>\n<p><strong>Hemangiomas (Option D) </strong>do not take up sulfur colloid and usually appear as cold areas but without the diffuse uptake pattern changes of cirrhosis.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250729451b6902-4656-4aa8-b62a-8be969c9326a.jpg\">\n<p><strong>Reference:</strong></p>\n<p>Grainger &amp; Allison's Diagnostic Radiology, 7th Edition, Page Number: 598</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">PET-CT</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">MDCT</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral flow study</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc sestamibi scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with a history of treated non-Hodgkin lymphoma presents for evaluation of suspected recurrence. The patient undergoes the imaging study shown below. Which investigation has been performed?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721621fb138-e169-4c5a-b93b-d613ba1c96bc.png\"></span></p>",
      "unique_key": "DT1282664",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The image shows combined metabolic and anatomical imaging using positron emission tomography (PET) with CT, characteristic of a <strong>PET-CT scan.</strong></p>\n<p><strong>PET-CT (Positron Emission Tomography-Computed Tomography):</strong></p>\n<ul>\n<li><strong>PET-CT</strong>is a hybrid imaging technique that combines <strong>functional PET imaging </strong>(typically using 18-FDG, a glucose analogue) with<strong> anatomical CT imaging</strong> in a single examination.</li>\n<li>It is commonly used in oncology for <strong>cancer staging, treatment planning, </strong>and <strong>monitoring,</strong>as well as in other areas such as neurology and cardiology.</li>\n<li><strong>PET imaging</strong>utilizes <strong>radioactive tracers</strong> that are taken up by cells based on their <strong>metabolic activity.</strong> This allows visualization of physiological processes such as <strong>glucose metabolism,</strong> which is often increased in cancer cells.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721f7eda713-7f6b-46c6-915b-0a2c3a0e87b0.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>MDCT (Multidetector Computed Tomography) (Option B)</strong> is a type of CT imaging that uses multiple rows of detectors to acquire data rapidly, enabling high-resolution imaging of anatomical structures.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721e02c2deb-4dbb-4e6a-b1ff-8c9d825c3626.png\">\n<p><strong>Cerebral flow study (Option C)</strong> typically involves imaging techniques such as perfusion MRI or SPECT to assess cerebral blood flow. These studies are primarily used in neurology to evaluate conditions such as stroke, ischemia, or neurodegenerative diseases.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507214b327e84-d93e-4e17-aa91-8f7f9c271a2f.png\">\n<p><strong>Tc sestamibi scan (Option D)</strong>, also known as a myocardial perfusion scan, is a nuclear medicine imaging technique used to assess blood flow to the heart muscle. It is primarily used in cardiology to diagnose coronary artery disease, evaluate myocardial viability, and assess cardiac function.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721599a4af2-41fb-40ea-87ad-bb99af82cb4e.png\">",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral spiculated mass with central necrosis</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Centrally located, well-defined enhancing endobronchial mass</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Poorly enhancing mass with calcifications in all cases</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Large heterogeneous mass with chest wall invasion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most characteristic imaging finding of a typical pulmonary carcinoid tumour on contrast-enhanced CT?</span></p>",
      "unique_key": "DT1282671",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282671,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Typical pulmonary carcinoids</strong> usually appear on CECT as <strong>centrally located, round, well-defined endobronchial lesions</strong> that show intense enhancement due to their vascularity.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507211b139cf5-759c-44a4-8beb-a50c00de5262.png\">\n<p><strong>Typical Carcinoids:</strong></p>\n<ul>\n<li><strong>Typical carcinoids </strong>are often <strong>less metabolically active </strong>(most often originate from the central bronchi) compared to other neuroendocrine tumours such as small cell carcinoma or large cell neuroendocrine carcinoma.</li>\n<li>On<strong> contrast-enhanced CT</strong>, they appear as well-marginated, round or oval endobronchial masses that enhance intensely, reflecting their rich capillary network.</li>\n<li>They may cause <strong>secondary findings</strong> such as airway obstruction, atelectasis, or mucoid impaction.</li>\n<li>Unlike more aggressive tumours, they typically do not show necrosis or invasion and may contain calcifications in a subset of cases (30%).</li>\n<li>Their imaging helps distinguish them from other central lung tumours like small cell carcinoma, which tends to show more aggressive features.</li>\n<li>They may not show significant uptake of fluorodeoxyglucose (FDG) on PET scans.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721c649d60d-36fa-494b-beff-e8cca7947166.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507213af0a2c7-4420-403e-b03f-0f8e4a95d068.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Peripheral spiculated mass with central necrosis ( Option A): </strong>This pattern is more typical of peripheral lung malignancies like adenocarcinoma, not carcinoids.</p>\n<p><strong>Poorly enhancing mass with calcifications in all cases (Option C): </strong>While calcification may be present, not all typical carcinoids show it, and the lesions usually enhance strongly.</p>\n<p><strong>Large heterogeneous mass with chest wall invasion (Option D):</strong> This describes an aggressive malignancy like small cell carcinoma or NSCLC with chest wall invasion, not typical carcinoid.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallium-67 citrate scan</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">18F-DOPA PET</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc-99m pertechnetate thyroid scan</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc-99m sestamibi scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following nuclear medicine techniques is most sensitive and commonly used for preoperative localization of parathyroid adenomas?</span></p>",
      "unique_key": "DT1282678",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tc-99m sestamibi scan </strong>is the most sensitive and widely used imaging modality for localizing parathyroid adenomas preoperatively.</p>\n<p><strong>Tc-99m Sestamibi scan (MIBI):</strong></p>\n<ul>\n<li>It is also known as <strong>parathyroid scintigraphy, </strong>and is considered the <strong>most sensitive </strong>imaging modality for <strong>localising adenomas of the parathyroid gland.</strong></li>\n<li><strong>Sestamibi</strong> accumulates in both thyroid and parathyroid tissue initially, but parathyroid adenomas retain the tracer longer due to higher mitochondrial content and blood flow.</li>\n<li>This allows for <strong>dual-phase imaging</strong> (early and delayed) to distinguish parathyroid adenomas from thyroid tissue.</li>\n<li>It is often combined with <strong>SPECT/CT </strong>for precise anatomical localization before surgery.</li>\n<li>This imaging plays a central role in minimally invasive parathyroidectomy.</li>\n</ul>\n<p><strong>Other Radioisotope studies and their uses:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025072129fe158d-868d-46bf-94b8-354a4cb557b7.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Gallium-67 citrate scan (Option A)</strong> is used for Lymphocyte Scintigraphy, and it shows the panda sign and lambda sign in sarcoidosis.</p>\n<p><strong>18-F DOPA-PET (Option B)</strong> is used for the assessment of extra-abdominal pheochromocytoma.</p>\n<p><strong>Tc99m-Pertechnate scan (Option C)</strong> is used for thyroid, functional scans, salivary scintigraphy, and Meckel's diverticulum.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Thallium 201 scan</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc 99m pyrophosphate scan</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Strontium 90 scan</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodine 127 scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following radiotracers is specifically used for scintigraphic imaging of acute myocardial infarction due to its affinity for calcium in necrotic tissue?</span></p>",
      "unique_key": "DT1282682",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tc-99m pyrophosphate </strong>accumulates in the necrotic myocardium by binding to calcium deposits, making it useful for imaging <strong>acute myocardial infarction.</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721c1e7fdd4-1846-455f-ae49-59706b0ee709.png\">\n<p><strong>Tc 99m pyrophosphate:</strong></p>\n<ul>\n<li>Tc-99m pyrophosphate (PYP) is used in <strong>acute myocardial infarct scintigraphy</strong> due to its property of binding to calcium deposits in necrotic myocardial cells.</li>\n<li>It is most effective within <strong>24-72 hours of infarction</strong>, where it highlights areas of recent infarction as \"<strong>hot spots</strong>\" on the scan.</li>\n<li>Unlike perfusion tracers (like thallium-201), Tc-99m PYP does not assess viability but rather indicates<strong> irreversible myocardial injury. </strong></li>\n<li>Less commonly used today due to advanced diagnostics like troponins and cardiac MRI.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thallium-201 scan (Option A):</strong> Thallium-201 is primarily used in myocardial perfusion imaging to detect ischemia and viability of heart tissue. It shows 'cold spots' where there is reduced blood flow.</p>\n<p><strong>Strontium-90 scan (Option C):</strong> Strontium-90 is not used in cardiac imaging. It is a beta-emitter and is used in radiotherapy.</p>\n<p><strong>Iodine-127 (I-127) scan (Option D):</strong> Iodine-127 is not used for cardiac imaging. The isotopes of iodine used in medical imaging are typically Iodine-123 (for diagnostic imaging in the thyroid) and Iodine-131 (for both diagnostic and therapeutic purposes in thyroid conditions).</p>\n<p><strong>Reference:</strong></p>\n<p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1878954/\">https://pmc.ncbi.nlm.nih.gov/articles/PMC1878954/</a></p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal angiography</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">DMSA scan</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">MAG-3 Scan</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc-99m DTPA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man presents with acute renal failure. His ultrasound shows normal-sized kidneys with no signs of obstruction. You decide to assess his glomerular filtration rate (GFR) to evaluate renal function. Which of the following is the most appropriate next investigation?</span></p>",
      "unique_key": "DT1282686",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tc-99m DTPA </strong>is a<strong> glomerular agent </strong>used specifically to measure<strong> GFR </strong>accurately and non-invasively in patients with renal dysfunction.</p>\n<p><strong>DTPA scan:</strong></p>\n<ul>\n<li><strong>DTPA</strong>(diethylenetriaminepentaacetic acid) scan, also known as a&nbsp;<strong>renal nuclear scan or renal scintigraphy.</strong></li>\n<li>It is an imaging test&nbsp;that assesses GFR.</li>\n<li>Tc-99m DTPA is a radiopharmaceutical that is exclusively filtered by the glomerulus, making it ideal for assessing <strong>glomerular filtration rate (GFR).</strong></li>\n<li>It provides both quantitative and functional data about <strong>renal perfusion </strong>and excretion.</li>\n<li>It involves the injection of a radioactive tracer (<strong>technetium-99m DTPA</strong>) intravenously, followed by gamma camera imaging to assess renal blood flow, glomerular filtration rate (GFR), and renal function.</li>\n<li>In patients with acute renal failure and a normal ultrasound, measuring GFR helps distinguish between pre-renal, intrinsic, and post-renal causes, and guides further management.</li>\n</ul>\n<p><strong>Other Tc99m scans are:</strong></p>\n<ul>\n<li><strong>Tc99m-DMSA scan (Option B)</strong>:&nbsp;Morphology, anatomy, and cortical scars in the kidney</li>\n<li><strong>Tc99m-DTPA Scan:</strong>Evaluates GFR</li>\n<li><strong>Tc99m-MAG3 Scan (Option C)</strong>:&nbsp;Renal perfusion, renal plasma flow and renal function</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Renal angiography (Option A)</strong> is used for the assessment of renal artery pathologies and is not used for the GFR measurement.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">A is true, but R is false</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">A is false, but R is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Assertion (A): PET scan is useful in differentiating radiation necrosis from tumour recurrence.<br>Reason (R): Radiation necrosis shows reduced metabolic activity on PET imaging, while recurrent tumours demonstrate increased FDG uptake.</span></p>",
      "unique_key": "DT1282692",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282692,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of answer:</strong></p>\n<p><strong>PET </strong>accurately distinguishes between<strong> tumour recurrence and radiation necrosis </strong>by analysing<strong> metabolic activity, </strong>which is elevated in tumours and low in necrosis. Radiation necrosis shows hypometabolism (low FDG uptake) due to the lack of viable tumour cells.</p>\n<p><strong>PET:</strong></p>\n<ul>\n<li><strong>Positron Emission Tomography</strong> (PET) scan is indeed one of the best imaging modalities for detecting and differentiating <strong>radiation-induced necrosis</strong> from <strong>tumour recurrence </strong>in the brain.</li>\n<li>PET scans can provide metabolic information by detecting areas of <strong>increased or decreased glucose metabolism.</strong></li>\n<li>In the context of <strong>radiation-induced necrosis, </strong>affected areas often show decreased glucose metabolism, referred to as<strong> cold spots.</strong></li>\n</ul>\n<p><strong>Radiation Necrosis:</strong></p>\n<ul>\n<li>Radiation necrosis is a late complication of radiotherapy, especially in the brain, and often mimics tumour recurrence on CT and MRI due to similar enhancing features.</li>\n<li>FDG-PET is valuable in differentiating the two:\n<ul>\n<li><strong>Recurrent tumours</strong> exhibit <strong>increased glucose metabolism</strong> (high FDG uptake)</li>\n<li><strong>Radiation necrosis</strong> shows <strong>hypometabolism</strong> (low FDG uptake) due to the lack of viable tumour cells.</li>\n</ul>\n</li>\n<li>This distinction is crucial for management, as necrosis may not need further oncologic treatment, while recurrence often does.</li>\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}